CM
Cearnal Martin E Other
US US · SEC (Form 4)
€3,751
▲ Purchases (14 ops.)
Explore the complete record of transactions filed by Cearnal Martin E. Director active across 1 companies, notably Cumberland Pharmaceuticals INC. Cumulatively, 17 reports have been recorded. Total volume traded: €4k. The latest transaction was disclosed on 17 March 2022 — J. Regulator: SEC (Form 4). The full history is free.
Declarations 17 total
€37,289 15,000 shares @ €2.4859 0.045% mcap 65.4% of flow
Common Stock
SEC:0001209191-22-026154:0 · 17 Mar 2022
€329 90 shares @ €3.6539 0.0004% mcap 3.3% of flow
Common Stock
SEC:0001209191-22-002447 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) €329 90 shares @ €3.6539 0.0004% mcap 0.6% of flow
Common Stock
SEC:0001209191-22-002447:0 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) €243 105 shares @ €2.3104 0.0003% mcap 2.5% of flow
Common Stock
SEC:0001209191-21-067878 · 1 Nov 2021
Ideal exit: 29 Jul 2022 (T+270) €243 105 shares @ €2.3104 0.0003% mcap 0.4% of flow
Common Stock
SEC:0001209191-21-067878:0 · 1 Nov 2021
Ideal exit: 29 Jul 2022 (T+270) €244 105 shares @ €2.3241 0.0003% mcap 2.5% of flow
Common Stock
SEC:0001209191-21-063217 · 1 Oct 2021
Ideal exit: 28 Jun 2022 (T+270) €244 105 shares @ €2.3241 0.0003% mcap 0.4% of flow
Common Stock
SEC:0001209191-21-063217:0 · 1 Oct 2021
Ideal exit: 28 Jun 2022 (T+270) €255 105 shares @ €2.4322 0.0003% mcap 2.6% of flow
Common Stock
SEC:0001209191-21-058506 · 1 Sept 2021
Ideal exit: 29 May 2022 (T+270) €255 105 shares @ €2.4322 0.0003% mcap 0.4% of flow
Common Stock
SEC:0001209191-21-058506:0 · 1 Sept 2021
Ideal exit: 29 May 2022 (T+270) €295 105 shares @ €2.8127 0.0004% mcap 3.0% of flow
Common Stock
SEC:0001209191-21-055478 · 2 Aug 2021
Ideal exit: 29 Apr 2022 (T+270) €295 105 shares @ €2.8127 0.0004% mcap 0.5% of flow
Common Stock
SEC:0001209191-21-055478:0 · 2 Aug 2021
Ideal exit: 29 Apr 2022 (T+270) €259 105 shares @ €2.4712 0.0003% mcap 2.6% of flow
Common Stock
SEC:0001209191-21-051433 · 30 Jun 2021
Ideal exit: 27 Mar 2022 (T+270) €259 105 shares @ €2.4712 0.0003% mcap 0.5% of flow
Common Stock
SEC:0001209191-21-051433:0 · 30 Jun 2021
Ideal exit: 27 Mar 2022 (T+270) €250 105 shares @ €2.3806 0.0003% mcap 2.5% of flow
Common Stock
SEC:0001209191-21-046210 · 18 May 2021
Ideal exit: 12 Feb 2022 (T+270) €250 105 shares @ €2.3806 0.0003% mcap 0.4% of flow
Common Stock
SEC:0001209191-21-046210:0 · 18 May 2021
Ideal exit: 12 Feb 2022 (T+270) €7,968 2,945 shares @ €2.7055 0.0097% mcap 80.9% of flow
Common Stock
SEC:0001209191-21-038980 · 17 Mar 2021
€7,968 2,945 shares @ €2.7055 0.0097% mcap 14.0% of flow
Common Stock
SEC:0001209191-21-038980:0 · 17 Mar 2021
About Cearnal Martin E Cearnal Martin E is an executive at Cumberland Pharmaceuticals Inc.